Topics
High-grade gliomas | Treatment | Targeted therapy | Olaparib
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Olaparib
Esparragosa Vazquez I, Sanson M, Chinot OL, Fontanilles M,
Rivoirard R, Thomas-Maisonneuve L, Cartalat S, Tabouret E, Appay
R, Bonneville-Levard A, Darlix A, Meyronet D, Barritault M,
Gueyffier F, Remontet L, Maucort-Boulch D, Honnorat J, Dehais C,
Ducray F; POLA Network.
Olaparib in
recurrent isocitrate dehydrogenase mutant high-grade glioma: A
phase 2 multicenter study of the POLA Network.
Neurooncol
Adv. 2024 May 27;6(1):vdae078. doi:
10.1093/noajnl/vdae078. PMID:
38855053. Interventional study. ˍ